Cite
HARVARD Citation
Arriga, R. et al. (2020). CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab. International journal of cancer. 146 (9), pp. 2531-2538. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arriga, R. et al. (2020). CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab. International journal of cancer. 146 (9), pp. 2531-2538. [Online].